Atlas Capital Advisors’s VanEck Biotech ETF BBH Stock Holding History

Atlas Capital Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Sell	5,450 -250	-4%	-$48.2K	0.12%	144
2025 Q4	$1.08M	Buy	+5,700	New	+$1.05M	0.12%	144
2025 Q2	$874K	Hold	5,700	–	–	0.11%	170
2025 Q1	$897K	Hold	5,700	–	–	0.11%	157
2024 Q4	$895K	Buy	+5,700	New	+$959K	0.11%	156
2024 Q3	–	Sell	-5,700	Closed	-$960K	–	911
2024 Q2	$960K	Buy	+5,700	New	+$932K	0.12%	132
2024 Q1	–	Sell	-5,700	Closed	-$942K	–	896
2023 Q4	$942K	Hold	5,700	–	–	0.14%	130
2023 Q3	$888K	Hold	5,700	–	–	0.15%	114
2023 Q2	$889K	Hold	5,700	–	–	0.13%	123
2023 Q1	$924K	Hold	5,700	–	–	0.15%	105
2022 Q4	$911K	Hold	5,700	–	–	0.15%	116
2022 Q3	$802K	Hold	5,700	–	–	0.15%	115
2022 Q2	$831K	Hold	5,700	–	–	0.14%	122
2022 Q1	$924K	Hold	5,700	–	–	0.14%	127
2021 Q4	$1.08M	Hold	5,700	–	–	0.16%	106
2021 Q3	$1.15M	Sell	5,700 -300	-5%	-$63K	0.18%	105
2021 Q2	$1.21M	Hold	6,000	–	–	0.2%	99
2021 Q1	$1.05M	Hold	6,000	–	–	0.2%	105
2020 Q4	$1.02M	Hold	6,000	–	–	0.21%	99
2020 Q3	$972K	Hold	6,000	–	–	0.23%	100
2020 Q2	$978K	Hold	6,000	–	–	0.23%	96
2020 Q1	$768K	Hold	6,000	–	–	0.23%	107
2019 Q4	$837K	Hold	6,000	–	–	0.21%	125
2019 Q3	$708K	Hold	6,000	–	–	0.21%	140
2019 Q2	$774K	Hold	6,000	–	–	0.25%	110
2019 Q1	$771K	Hold	6,000	–	–	0.28%	104
2018 Q4	$664K	Hold	6,000	–	–	0.27%	100
2018 Q3	$810K	Hold	6,000	–	–	0.27%	100
2018 Q2	$771K	Hold	6,000	–	–	0.27%	107
2018 Q1	$722K	Buy	+6,000	New	+$753K	0.22%	141

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Atlas Capital Advisors's BBH Position: Q1 2026 in Review

Atlas Capital Advisors reduced its VanEck Biotech ETF (BBH) stake by 4.4% in Q1 2026, selling an estimated $48.2K and leaving 5,450 shares worth $1.02M. The position accounts for 0.12% of the portfolio, ranked #144.

Atlas Capital Advisors first reported a position in BBH in Q1 2018 and has held it in 30 quarters since. The position peaked at $1.21M in Q2 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Atlas Capital Advisors held 5,450 shares of VanEck Biotech ETF worth $1.02M as of Q1 2026.
Atlas Capital Advisors sold 250 VanEck Biotech ETF shares in Q1 2026, an estimated $48.2K.
VanEck Biotech ETF made up 0.12% of Atlas Capital Advisors's portfolio in Q1 2026, its #144 holding.
Atlas Capital Advisors first reported a position in VanEck Biotech ETF in Q1 2018 and has held it in 30 quarters since.
Atlas Capital Advisors's VanEck Biotech ETF position peaked at $1.21M in Q2 2021.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.